Cord blood stem cells aim to reverse stroke damage in new trial
NCT ID NCT06129175
First seen Jan 05, 2026 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tests whether a single infusion of stem cells from donated umbilical cord blood (Neuroncell-EX) can help people recover better after a moderate to severe stroke. About 80 adults who had a stroke within the past 4 weeks and cannot receive standard clot-busting drugs will be randomly assigned to get the stem cells or a placebo. The main goal is to see if the treatment improves daily living skills and reduces disability over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Canselor Tuanku Muhriz UKM
RECRUITINGCheras, Kuala Lumpur, 56000, Malaysia
Contact
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.